MobileODT

MobileODT

MobileODT

Dedicated to bringing fast, powerful, inexpensive and mobile technology to help identify cancers and lesions anywhere, at anytime.
Type
B2b
Founded
2012
Raised
$10.8M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$4,000,000
Venture capital (Series C) - 2020
OrbiMed Israel Partners Tristel Tara Health +1
$6,825,000
Venture capital (Series B) - 2017
OrbiMed Advisors Tristel plc
Team Size
2
Employees
Location
Headquarters
$4,000,000 Venture capital (Series C)
FinSMEs

MobileODT Closes $4M in Series C Round

$6,825,000 Venture capital (Series B)
PE HUB

MobileODT attracts $6.825 mln Series B in OrbiMed-led round

Messaging
Geektime

MobileODT gets FDA approval for phone-based cervical cancer detection system

Health